Possible role of FDG-PET in the early prediction of therapy outcome in liver metastases of colorectal cancer

Hybridoma

Volumn 18, Issue 1, 1999, Pages 87-91

  Bender, Hans ^a   Bangard, Nicole ^b   Metten, Nina ^b   Bangard, Michael ^b   Mezger, Jörg ^b   Schomburg, Axel ^b   Biersack, Hans Jürgen ^b  

^a UNIVERSITY OF BONN   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE; FLUOROURACIL; FOLINIC ACID;

ADULT; AGED; CANCER INHIBITION; CLINICAL ARTICLE; CLINICAL TRIAL; COLORECTAL CANCER; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; GLUCOSE UTILIZATION; HUMAN; IMAGING; LIVER METASTASIS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; TREATMENT OUTCOME; TUMOR VOLUME; ULTRASOUND;

EID: 0033037874     PISSN: 0272457X     EISSN: None     Source Type: Journal    
DOI: 10.1089/hyb.1999.18.87     Document Type: Conference Paper

References (17)

1. Advanced Colorectal Cancer Meta-analysis Project: Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer in terms of response rate. J Clin Oncol 1992;10:896-903.
2. Rigo P, Paulus P, Kaschten BJ, et al.: Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose. Eur J Nucl Med 1996;23:1641-1674.
3. Wahl RL, Hutchins GD, Buchsbaum DJ, et al.: 18F-2-deoxy-2-fluoro-D-glucose uptake into human tumor xenografts. Feasibility studies for cancer imaging with positron-emission tomography. Cancer 1991;67:1544-1550.
4. Paulus P, Hustinx R, Daenen F, et al.: Usefulness of 18FDG positron emission tomography in detection and follow-up of digestive cancers. Acta Gastroenterol Belg 1997;60:278-280.
5. Gupta N, and Bradfield H: Role of positron emission tomography scanning in evaluating gastrointestinal neoplasms. Semin Nucl Med 1996;26:65-73.
6. Okada J, Yoshikawa K, Itami M, et al.: Positron emission tomography using fluorine-18-fluorodeoxyglucose in malignant lymphoma: A comparison with proliferative activity. J Nucl Med 1992;33:325-329.
7. Haberkorn U, Strauss LG, Reisser C, et al.: Glucose uptake perfusion, and cell proliferation in head and neck tumors: Relation of positron emission tomography to flow cytometry. J Nucl Med 1991;32:1548-1555.
8. Minn H, Joensuu H, Ahonen A, et al.: Fluorodeoxyglucose imaging: a method to assess the proliferative activity of human cancer in vivo. Comparison with DNA flow cytometry in head and neck tumors. Cancer 1988;61:1776-1781.
9. Higashi K, Clavo AC, and Wahl RL: Does FDG uptake measure proliferative activity of human cancer cells? In vitro comparison with DNA flow cytometry and tritiated thymidine uptake. J Nucl Med 1993;34:414-419.
10. Minn H, Paul R, and Ahonen A: Evaluation of treatment response to radiotherapy in head and neck cancer with FDG. J Nucl Med 1988;29:1521-1525.
11. Okazumi S, Isono K, Enomoto K, et al.: Evaluation of liver tumors using FDG-PET: Characterization of tumor and assessment of effect of treatment. J Nucl Med 1992;33:333-339.
12. Wahl RL, Zasadny K, Helvie M, et al.: Metabolic monitoring of breast cancer chemohormontherapy using PET: Initial evaluation. J Clin Oncol 1993;11:2101-2111.
13. Findlay M, Young H, Cunningham D, et al.: Noninvasive monitoring of tumor metabolism using fluorodeoxyglucose and positron emission tomography in colorectal cancer liver metastases: correlation with tumor response to fluorouracil. J Clin Oncol 1996;14:700-708.
14. Miller AB, Hoogstraaten B, Staquet M, et al.: Reporting results of cancer treatment. Cancer 1981;47:207-214.
15. Schomburg A, Bender H, Reichel C, et al.: Standardized uptake values of fluorine-18 deoxyglucose: The value of different normalization procedures. Eur J Nucl Med 1996;23:571-574.
16. Ichiya Y, Kuwabara Y, Otsuka M, et al.: Assessment of response to cancer therapy using FDG and PET. J Nucl Med 1991;2:1655-1660.
17. Hoekestra O, Ossenkoppele GJ, Golding R, et al.: Early treatment response in malignant lymphoma, as determined by planar FDG scintigraphy. J Nucl Med 1993;34:254-260.